Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000108

Director sold 1,666 shares at an average $52.81 ($87,983)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2021-11-10 Sale −1,006 $52.49 $52,805 126,827 D: show line 1 in the form
SATO VICKI L Director 2021-11-10 Sale −660 $53.30 $35,178 126,167 D: show line 2 in the form
Open-market sales · 1,666 sh · avg $52.81 · $87,983
Loading xslF345X03/wf-form4_163675267254090.xml…